A
Agilent Technologies, Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$150.98
+0.67%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
23.0x
EV/EBITDA
22.7x
Market Cap
$42.57B
MomentumView details →
1D Return
+0.67%
YTD Return
+9.88%
RSI (14)
51.6
ValuationView details →
P/E (Fwd)
23.0x
EV/EBITDA
22.7x
Market Cap
$42.57B
RSI (14)
51.6
MomentumView details →
1D Return
+0.67%
YTD Return
+9.88%
SummaryUpdated Jul 1, 2026
Agilent Technologies, Inc. (NYSE:A) is a leading scientific instrumentation and laboratory solutions company founded in 1999 as a spin-off from Hewlett-Packard Company. Headquartered in Santa Clara, California, Agilent has evolved into a global provider of analytical instruments, software, services, and consumables serving the life sciences, diagnostics, and applied chemical markets. The company operates through three primary business segments and serves customers across pharmaceutical, biotechnology, academic, government, environmental, forensic, food, and chemical industries worldwide.
Similar companies
Latest newsMore news →
Agilent Technologies launched the Agilent S540MD Slide Scanner System in the U.S. after receiving FDA clearance, expanding its digital pathology portfolio.4h agoAgilent Technologies reported Q3 2026 revenue of $1.88 billion, growing 7.3% on a core basis, and issued FY2026 guidance.9d agoAgilent Technologies reported Q3 2026 revenue of $1.878 billion, up 8.1% year-over-year, with net income of $362 million and diluted EPS of $1.28.10d ago